Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

January 31, 2008

Study Completion Date

December 31, 2012

Conditions
Borderline Personality Disorder
Interventions
DRUG

Fluoxetine

Fluoxetine is administered in standard dosing 20, 40, 60, 80 mg increased monthly if tolerated

BEHAVIORAL

Dialectical Behavior Therapy

Dialectical Behavior Therapy is a form of CBT originally developed to treat suicidal and self injuring individuals with borderline personality disorder. Treatment consists of 2 sessions/week: individual psychotherapy and skills training group.

BEHAVIORAL

Supportive psychotherapy

Supportive therapy is a manualized form of psychotherapy designed to enhance individual's strengths and coping mechanisms while reducing distress.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00533117 - Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder | Biotech Hunter | Biotech Hunter